Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
Stopped The study is not initiated and we want it to be withdrawn.
Conditions
- Acute Myeloid Leukemia (AML)
- B-cell Non-Hodgkin's Lymphoma (B-NHL)
- Multiple Myeloma (MM)
- T-Cell Leukemia/Lymphoma, Adult
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
Interventions
- BIOLOGICAL: Autologous CAR-T cells
- DRUG: Fludarabine
- DRUG: Cyclophosphamide
Sponsor
Shanghai Pudong Hospital
Collaborators